Optigenex(OTC) OPGX

Market CapN/A

Since IPO (2005)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0.00%

+0.00Today

Optigenex last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-03

Optigenex stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-23
1 month	+0%	USD 0.00	2026-06-26
3 month	+0%	USD 0.00	2026-04-30
Year to date	+0%	USD 0.00	2025-12-31
1 year	+0%	USD 0.00	2025-07-21
3 year	-99.97%	USD 1.00	2023-07-24
5 year	-99.96%	USD 0.75	2021-08-04
Since inception	-100%	USD 637,525.50	2005-04-15

Optigenex Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$634.51K

Net Income (TTM)

-$3.91M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

302.27 (High)

Dividend

$0.00

Beta (Volatility)

302.27 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

302.27 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

N/A

OPGX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Optigenex

Optigenex Inc. is a healthcare company focused on producing and distributing products that promote healthy aging and enhance beauty. The company specializes in AC-11, a potent extract from rainforest plants that aids in DNA repair and skin rejuvenation.

Products and Services

AC-11, a bioactive ingredient for skincare and dietary supplements
Products targeting anti-aging and beauty enhancement
Distribution to manufacturers, retailers, and distributors globally

Growth Outlook

Increasing demand for anti-aging products in global markets
Expansion into new sectors, including cosmeceuticals
Potential for strategic partnerships to enhance distribution

Financial Highlights

Recent quarterly revenue of 182,820, showing growth potential
Net income of 1,014,600 in the latest quarter
Operating income margin of 1.07, indicating operational efficiency

Optigenex Inc. operates in the Medical - Diagnostics & Research industry, with a focus on innovative solutions for aging and beauty. The company’s flagship product, AC-11, is designed to assist in repairing DNA damage, which is increasingly relevant in today's health-conscious market. The global demand for anti-aging products continues to rise, positioning Optigenex to capitalize on this trend. Recent financial performance indicates a positive trajectory, with significant revenue and net income reported in the latest quarter. The company is also exploring opportunities for expansion and partnerships, which could further enhance its market presence and operational capabilities.

AI Generated • Jul 30, 2026

Industry

Chemicals

Sector

Materials

Headquarters

Melissa, TX 75454, US

OPGX Financials

Key Financial Metrics (TTM)

Gross Margin

-22.10%

Operating Margin

298.48%

Net Income Margin

-621.88%

Return on Equity

46.25%

Return on Capital

110.52%

Return on Assets

-153.46%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

400

Volume

Avg. Volume

11.524

Financials (TTM)

Gross Profit

-$16.48K

Operating Income

$1.13M

EBITDA

$1.84M

Operating Cash Flow

-$176.38K

Capital Expenditure

$0.00

Free Cash Flow

-$176.38K

Cash & ST Invst.

$21.40K

Total Debt

$11.43M

Optigenex Performance Analysis

Optigenex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2007-09-30	63.4%
Q4	2007-12-31	-29.8%
Q1	2008-03-31	84.8%
Q2	2008-06-30	-6.4%

Optigenex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2007-09-30	N/A
Q4	2007-12-31	-100.0%
Q1	2008-03-31	N/A
Q2	2008-06-30	100.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2008YOY CHG

Revenue

$182.82K

+98.4%

Gross Profit

$119.04K

+81.7%

Gross Margin

65.11%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.01M

+237.1%

EBITDA

-$196.42K

+36.8%

Quarterly Fundamentals

Name

Q2 2008YOY CHG

Total Cash

$21.40K

-50.0%

Total Debt

$11.43M

+62.9%

Accounts Receivable

$0.00

-100.0%

Inventory

$368.93K

-56.9%

Long Term Debt

$3.24M

-53.7%

Short Term Debt

$8.18M

N/A

Return on Assets

-1.53%

N/A

Return on Invested Capital

-44.42%

N/A

Free Cash Flow

-$137.94K

-15.6%

Operating Cash Flow

-$137.94K

-15.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MHTXManhattan Scientifics, Inc.

MHTXManhattan Scientifics, Inc.$0.00+0.00%

BIOIFBiome Grow Inc.

BIOIFBiome Grow Inc.$0.00+0.00%

CBGLCannabis Global Inc.

CBGLCannabis Global Inc.$0.00+0.00%

SPPHSpencer Pharmaceutical Inc.

SPPHSpencer Pharmaceutical Inc.$0.00+0.00%

LADXLadRx Corporation

LADXLadRx Corporation$0.01-89.72%

IMMBImmunotech Laboratories, Inc.

IMMBImmunotech Laboratories, Inc.$0.00+0.00%

ABMTAdvanced BioMedical Technologies Inc.

ABMTAdvanced BioMedical Technologies Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PLTRPalantir Technologies

PLTRPalantir Technologies$162.66+0.29%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$125.33+0.09%

NVDANvidia

NVDANvidia$211.94+0.03%

INTCIntel

INTCIntel$100.86+0.11%

AMIXAutonomix Medical

AMIXAutonomix Medical$19.50+4.34%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$8.07+0.03%

NOKNokia

NOKNokia$9.92+0.06%

Questions About OPGX

What is the current price of Optigenex?

Optigenex is trading at $0.00 per share.

What is the 52-week range for Optigenex?

Over the past 52 weeks, Optigenex has traded between $0.00 and $0.04.

How much debt does Optigenex have?

Optigenex total debt is unavailable.

How much cash does Optigenex have on hand?

Optigenex does not have cash on hand data available.

What is Optigenex’s dividend yield?

Optigenex does not currently have a dividend yield.

Optigenex(OTC) OPGX

Optigenex Financials at a Glance

OPGX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Optigenex

OPGX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Optigenex Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OPGX

What is the current price of Optigenex?

What is the 52-week range for Optigenex?

How much debt does Optigenex have?

How much cash does Optigenex have on hand?

What is Optigenex’s dividend yield?

Premium Investing Services